-
公开(公告)号：US10881664B2
公开(公告)日：2021-01-05
申请号：US15574347
申请日：2016-05-12
Applicant: Novartis AG
Inventor： NgocDiep Le , Gerald Lelais , Yong Jia
Abstract: Methods for the treatment of EGFR mutated cancer. For example, treatment of non-small cell lung cancer (NSCLC) with activating EGFR mutations (e.g., L858R and ex19del) the acquired or resistant “gatekeeper” T790M mutation, or any combination of these mutations.
Search Results
1
records
(took 0.008 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
